Scilex Holding Company Debt Instrument, Fair Value Disclosure
Scilex Holding Company (SCLX) had Debt Instrument, Fair Value Disclosure of $9.44 thousand as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2023-03-07
- 2022-03-31: Debt Instrument, Fair Value Disclosure $9.44K.
- 2021-12-31: Debt Instrument, Fair Value Disclosure $115.40M; Debt Instrument, Fair Value Disclosure as first filed $16.90K.
| Period end | Debt Instrument, Fair Value Disclosure | Debt Instrument, Fair Value Disclosure as first filed |
|---|---|---|
| 2022-03-31 | $9.44K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $115.40M 10-K · filed 2023-03-07 | $16.90K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |